Pfizer and Moderna vaccines greatly increase the risk of dangerous heart disease

The risk of developing acute coronary syndrome (ACS) increased significantly in patients after receiving the COVID-19 mRNA vaccine. The data is presented in a report presented at the 2021 American Heart Association (AHA) Scientific Sessions, held from November 13 to 15, 2021. It is reported by Cardiology Advisor.

The study involved 566 men and women (1: 1) aged 28-97 years. All participants were patients in preventive cardiac practice. Patients underwent a new PULS cardiac test 2-10 weeks after the second COVID-19 vaccine was administered. This test result was compared to the PULS score 3-5 months prior to vaccination.

Cordial The PULS test measures several protein biomarkers, including hepatocyte growth factor [HGF], soluble Fas, and IL-16. PULS uses the results to calculate a 5-year risk assessment for a new CCS. The PULS score increases as the level rises above normal. All participants took this test every 3-6 months for 8 years.

IL-16 level increased from period before vaccination to period after vaccination from 35 = / - 20 to 82 = / - 75 above the norm. Soluble Fas showed an increase from 22 ± 15 to 46 = / - 24 above normal. HGF (hepatocyte growth factor) increased from 42 ± 12 to 86 ± 31 above normal. As a result, the 5-year risk assessment of ACS PULS increased from 11% to 25%. At the time of publication of the report, the changes persisted for 2,5 months or more after the second dose of the vaccine.

The author of the study concluded that "mRNA [vaccines] dramatically increase endothelial inflammation and infiltration of cardiac muscle T-lymphocytes and may be the cause of increased thrombosis, cardiomyopathy, and other vascular problems after vaccination."